[Active vaccinations in multiple sclerosis].
Flachenecker
P
P
Klinische Forschungsgruppe für Multiple Sklerose, Neurologische Klinik und Poliklinik, Universität Würzburg.
Toyka
K V
KV
Hartung
H P
HP
D000328:Adult; D000367:Age Factors; D002648:Child; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007116:Immunization, Passive; D007252:Influenza Vaccines / Q000008:administration & dosage; D008458:Measles Vaccine / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000628:therapy*; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D012307:Risk Factors; D014611:Vaccination; D017778:Vaccines, Combined / Q000008:administration & dosage
D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D008458:Measles Vaccine; D011054:Poliovirus Vaccine, Inactivated; D017778:Vaccines, Combined
Aktive Schutzimpfungen bei multipler Sklerose.